These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11786898)

  • 1. Shedding growth factors in cardiac hypertrophy.
    Liao JK
    Nat Med; 2002 Jan; 8(1):20-1. PubMed ID: 11786898
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiac hypertrophy is inhibited by antagonism of ADAM12 processing of HB-EGF: metalloproteinase inhibitors as a new therapy.
    Asakura M; Kitakaze M; Takashima S; Liao Y; Ishikura F; Yoshinaka T; Ohmoto H; Node K; Yoshino K; Ishiguro H; Asanuma H; Sanada S; Matsumura Y; Takeda H; Beppu S; Tada M; Hori M; Higashiyama S
    Nat Med; 2002 Jan; 8(1):35-40. PubMed ID: 11786904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Membrane-anchored heparin-binding EGF-like growth factor processing by ADAM12 in cardiac hypertrophy].
    Higashiyama S
    Nihon Rinsho; 2003 May; 61(5):767-75. PubMed ID: 12755001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PACSIN3 binds ADAM12/meltrin alpha and up-regulates ectodomain shedding of heparin-binding epidermal growth factor-like growth factor.
    Mori S; Tanaka M; Nanba D; Nishiwaki E; Ishiguro H; Higashiyama S; Matsuura N
    J Biol Chem; 2003 Nov; 278(46):46029-34. PubMed ID: 12952982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A metalloprotease-disintegrin, MDC9/meltrin-gamma/ADAM9 and PKCdelta are involved in TPA-induced ectodomain shedding of membrane-anchored heparin-binding EGF-like growth factor.
    Izumi Y; Hirata M; Hasuwa H; Iwamoto R; Umata T; Miyado K; Tamai Y; Kurisaki T; Sehara-Fujisawa A; Ohno S; Mekada E
    EMBO J; 1998 Dec; 17(24):7260-72. PubMed ID: 9857183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor.
    Kodama T; Ikeda E; Okada A; Ohtsuka T; Shimoda M; Shiomi T; Yoshida K; Nakada M; Ohuchi E; Okada Y
    Am J Pathol; 2004 Nov; 165(5):1743-53. PubMed ID: 15509542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands.
    Sahin U; Weskamp G; Kelly K; Zhou HM; Higashiyama S; Peschon J; Hartmann D; Saftig P; Blobel CP
    J Cell Biol; 2004 Mar; 164(5):769-79. PubMed ID: 14993236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAM-mediated ectodomain shedding of HB-EGF in receptor cross-talk.
    Higashiyama S; Nanba D
    Biochim Biophys Acta; 2005 Aug; 1751(1):110-7. PubMed ID: 16054021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF.
    Prenzel N; Zwick E; Daub H; Leserer M; Abraham R; Wallasch C; Ullrich A
    Nature; 1999 Dec 23-30; 402(6764):884-8. PubMed ID: 10622253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The metalloprotease Kuzbanian (ADAM10) mediates the transactivation of EGF receptor by G protein-coupled receptors.
    Yan Y; Shirakabe K; Werb Z
    J Cell Biol; 2002 Jul; 158(2):221-6. PubMed ID: 12119356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer.
    Carl-McGrath S; Lendeckel U; Ebert M; Roessner A; Röcken C
    Int J Oncol; 2005 Jan; 26(1):17-24. PubMed ID: 15586220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reprolysins and astacins...alive, alive-o.
    Weinmaster G
    Science; 1998 Jan; 279(5349):336-7. PubMed ID: 9454330
    [No Abstract]   [Full Text] [Related]  

  • 13. Metalloproteinase-mediated shedding of heparin-binding EGF-like growth factor and its pathophysiological roles.
    Higashiyama S
    Protein Pept Lett; 2004 Oct; 11(5):443-50. PubMed ID: 15544565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TACE cleavage of proamphiregulin regulates GPCR-induced proliferation and motility of cancer cells.
    Gschwind A; Hart S; Fischer OM; Ullrich A
    EMBO J; 2003 May; 22(10):2411-21. PubMed ID: 12743035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ADAM binding protein Eve-1 is required for ectodomain shedding of epidermal growth factor receptor ligands.
    Tanaka M; Nanba D; Mori S; Shiba F; Ishiguro H; Yoshino K; Matsuura N; Higashiyama S
    J Biol Chem; 2004 Oct; 279(40):41950-9. PubMed ID: 15280379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ADAMs: modulators of cell-cell and cell-matrix interactions.
    White JM
    Curr Opin Cell Biol; 2003 Oct; 15(5):598-606. PubMed ID: 14519395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ADAM 12, a disintegrin metalloprotease, interacts with insulin-like growth factor-binding protein-3.
    Shi Z; Xu W; Loechel F; Wewer UM; Murphy LJ
    J Biol Chem; 2000 Jun; 275(24):18574-80. PubMed ID: 10849447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shedding light on sheddases: role in growth and development.
    Kheradmand F; Werb Z
    Bioessays; 2002 Jan; 24(1):8-12. PubMed ID: 11782944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAMs: focus on the protease domain.
    Black RA; White JM
    Curr Opin Cell Biol; 1998 Oct; 10(5):654-9. PubMed ID: 9818177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ADAM 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3.
    Loechel F; Fox JW; Murphy G; Albrechtsen R; Wewer UM
    Biochem Biophys Res Commun; 2000 Nov; 278(3):511-5. PubMed ID: 11095942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.